PD-L1 inhibitor
2 stories
-
healthImaging Sign of Immune Response Linked to Better Survival in Biliary Tract Cancer
Radiologically detected immune-related adverse events may help predict better outcomes in advanced biliary tract cancer patients on durvalumab-based therapy.
-
healthImmunotherapy Advances in Urothelial Bladder Cancer Treatment
Exploring how immunotherapy harnesses the immune system to fight urothelial bladder cancer, with key treatment types and breakthroughs.